Green Thumb: Canaccord Lowers Price Target After Earnings Missed Estimates

On November 10th, Green Thumb Industries (CSE: GTII) reported its third quarter financial results. The company reported revenues of $233.7 million, an increase of 5.3% increase quarter over quarter but a 48.7% increase year over year. Gross profits meanwhile came in at $129.52 million for the quarter and the firm posted a positive net income of $21.58 million or earnings per share of $0.08. The company indicated that adjusted EBTIDA was $81.2 million, up 2.4% quarter over quarter and 52.6% year over year.

A number of analysts changed their 12-month price targets on Green Thumb, bringing the average 12-month price target to C$58.19 or a 71.5% upside to the current price. Green Thumb currently has 16 analysts covering it, with 4 analysts having a strong buy rating and the other 12 have buy ratings. The street high sits at C$80 from Stifel-GMP while the lowest comes in at C$40.

In Canaccord’s third quarter review they reiterate their buy rating but lowered their 12-month price target to C$53 from C$56, saying, “A clean print amid a slower macro environment.” They additionally believe that the results in the face of a tough backdrop “is a testament to the company’s ability to navigate through sector headwinds while maintaining its profitability profile.”

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

For the quarter, Green Thumb slightly missed on all of Canaccord’s estimates, specifically Canaccord forecasted revenues of $234.62 million, adjusted EBITDA of $84.05 million, and earnings per share of $0.10. Canaccord says that this quarter’s outperformance versus its peers is due to closing multiple tack-on acquisitions which included 5 new retail stores.

For the company’s gross margin, Canaccord is very happy with it being flat quarter over quarter as the company saw decelerating revenue.

Below you can see Canaccord’s updated 2021 and 2022 estimates.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

Cronos: Raymond James Remains Bullish Despite Revenue Miss

Cronos Group (TSX: CRON) (NASDAQ: CRON) reported its first-quarter financial results on Friday, May 7th....

Tuesday, May 11, 2021, 05:47:00 PM

Trican Well Service: Consensus Price Target Rises To $3.26

On July 27, Trican Well Service (TSX: TCW) reported their second-quarter financials. The company reported...

Sunday, August 1, 2021, 12:06:00 PM

Stifel: WELL Health Is A “Unique Business Model Still In High Growth Phase”

Earlier this month, WELL Health Technologies (TSX: WELL) reported their second quarter financials, with quarterly...

Sunday, August 23, 2020, 04:05:00 PM

Tesla: Canaccord Lowers Target To $812 Off 4680 Cell Delay

Tesla Inc (NASDAQ: TSLA) founder Elon Musk has been in the news quite a bit...

Monday, June 14, 2021, 05:38:00 PM

Antibe Therapeutics: Canaccord Initiates Coverage, Issues $1.50 Price Target

Recently, Canaccord Genuity’s Tania Gonsalves initiated coverage on Antibe Therapeutics (TSXV: ATE), a biotechnology company...

Tuesday, August 18, 2020, 01:46:28 PM